Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy -- an analysis of the DiaRegis registry

Conclusion:
The present study suggests, that co-morbidity but not average glycaemic control reduces health related quality of life in type 2 diabetes mellitus.

Source: Cardiovascular Diabetology - March 20, 2013 Category: Cardiology Authors: Jürgen WasemPeter BramlageAnselm GittChristiane BinzMichael KreklerEvelin DeegDiethelm Tschöpe Source Type: research